DNA-shredding CRISPR enzyme takes aim at cancer cells
(feeds.nature.com)
1.
2.
Novartis to Buy Myricx Bio for Up to $1.5 Billion
(feeds.content.dowjones.io)
3.
A 1970s patent that changed the course of commercial biotechnology
(feeds.nature.com)
4.
Are microbes the future of pollution clean-up?
(feeds.nature.com)
5.
Peptides: where to begin?
(news.ycombinator.com)
6.
Why the US needs a unified, mission-based strategy for health innovation
(feeds.nature.com)
7.
Lab-grown oesophagus restores pigs’ ability to swallow
(feeds.nature.com)
8.
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
(feeds.content.dowjones.io)
9.
Opinion | America Is Losing the Biotech Fight to China
(feeds.content.dowjones.io)
10.
Pfizer ended up passing on my GLP-1 work back in the early '90s (2024)
(news.ycombinator.com)
11.
Startup Lifordi Seeks to Deliver Potent Medication for Autoimmune Diseases
(feeds.content.dowjones.io)
12.
Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion
(feeds.content.dowjones.io)